argipressin (4-9) has been researched along with relcovaptan in 1 studies
Studies (argipressin (4-9)) | Trials (argipressin (4-9)) | Recent Studies (post-2010) (argipressin (4-9)) | Studies (relcovaptan) | Trials (relcovaptan) | Recent Studies (post-2010) (relcovaptan) |
---|---|---|---|---|---|
36 | 0 | 0 | 120 | 9 | 40 |
Protein | Taxonomy | argipressin (4-9) (IC50) | relcovaptan (IC50) |
---|---|---|---|
Vasopressin V1a receptor | Homo sapiens (human) | 0.013 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dayanithi, G; Gouzènes, L; Moos, FC | 1 |
1 other study(ies) available for argipressin (4-9) and relcovaptan
Article | Year |
---|---|
Vasopressin(4-9) fragment activates V1a-type vasopressin receptor in rat supraoptic neurones.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium; Fluorescent Dyes; Fura-2; Hormone Antagonists; In Vitro Techniques; Indoles; Male; Morpholines; Neurons; Peptide Fragments; Pyrrolidines; Rats; Rats, Wistar; Receptors, Vasopressin; Spiro Compounds; Supraoptic Nucleus | 1999 |